2U3:FRA
Alcon AG
60,84 €
arrow_upward
+1,23%(+0,74) 1 p
7. aug, 15:31:44 GMT +2 · EUR
search
Kõik sümbolid
1 p
5 p
1 kuu
6 kuud
YTD
1 a
5 a
MAX
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse 2U3 põhistatistika genereerimine…
Ava
60,82 €
Kõrge
61,10 €
Madal
60,82 €
Turu kapit.
28,72Â mld
Keskm. maht
166,00
Maht
158,00
52 näd kõrgeim
76,64 €
52 näd madalaim
51,78 €
Töötajate arv
25Â tuh
Ava
60,82 €
Kõrge
61,10 €
Madal
60,82 €
Turu kapit.
28,72Â mld
Keskm. maht
166,00
Maht
158,00
52 näd kõrgeim
76,64 €
52 näd madalaim
51,78 €
Töötajate arv
25Â tuh
Uudised
Erinevatest veebiallikatest
https://www.dars.gov.et/
·
1 kuu eest
Alcon Inc. (ALC) Q1 2026 Earnings: EPS Beats Estimates as Eye Care Leader Delivers Resilient Results
Profiil
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
Teave üksuse Alcon AG kohta
TegevjuhtDavid J. Endicott
Töötajad25 tuh
Asutatud1945
PeakontoridGenf, Genf, Å veits
Sektor-
Veebisaitalcon.com
AI genereeritud sisu võib sisaldada vigu. Lisateave